SHAREHOLDER ALERT: Rigrodsky Law, P.A. Announces Investigation of Second Sight Medical Products, Inc. Merger

Wilmington, Delaware--(Newsfile Corp. - February 18, 2022) - Rigrodsky Law, P.A. announces that it is investigating Second Sight Medical Products, Inc. ("Second Sight") (NASDAQ: EYES) regarding possible breaches of fiduciary duties and other violations of law related to Second Sight's agreement to be acquired by Nano Precision Medical, Inc. ("Nano"). Under the terms of the agreement, Nano's shareholders will receive a total of 134 million shares of Second Sight common stock.

To learn more about this investigation and your rights, visit:

You may also contact Seth D. Rigrodsky or Gina M. Serra cost and obligation free at (888) 969-4242 or

Rigrodsky Law, P.A., with offices in Delaware and New York, has recovered hundreds of millions of dollars on behalf of investors and achieved substantial corporate governance reforms in securities fraud and corporate class actions nationwide.

Attorney advertising. Prior results do not guarantee a similar outcome.


Rigrodsky Law, P.A.
Seth D. Rigrodsky
Gina M. Serra
(888) 969-4242 (Toll Free)
(302) 295-5310
Fax: (302) 654-7530

To view the source version of this press release, please visit